Safety, Efficacy, and Pharmacokinetic Behavior of Leuprolide Mesylate (LMIS 25 mg) in Subjects With Prostate Cancer
Clinical trial NCT03261999 · COMPLETED
Trial details
- NCT number
- NCT03261999
- Sponsor
- Foresee Pharmaceuticals Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-26
- Primary completion
- 2018-11-19
- Enrollment
- 144
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.